DSpace at RU >

Browsing by Author Hill, A.

Full Text	Issue Date	Title	Author(s)
	2012	Pharmacokinetics of and short-term virologic response to low-dose 400-milligram once-daily raltegravir maintenance therapy.	Ananworanich, J.; Gorowara, M.; Avihingsanon, A.; Kerr, S.J.; Heesch, N. van, et al
	2010	Pharmacokinetics of low-dose protease inhibitors and efavirenz in low- and middle-income countries.	Gorowara, M.; Burger, D.M.; Hill, A.; Ruxrungtham, K.
	2007	Effect of the complement inhibitor eculizumab on thromboembolism in patients with paroxysmal nocturnal hemoglobinuria.	Hillmen, P.; Muus, P.; Duhrsen, U.; Risitano, A.M.; Schubert, J., et al
	2007	Ketoconazole is inferior to ritonavir as an alternative booster for saquinavir in a once daily regimen in Thai HIV-1 infected patients.	Autar, R.S.; Wit, F.W.; Sankote, J.; Sutthichom, D.; Kimenai, E., et al
	2006	The complement inhibitor eculizumab in paroxysmal nocturnal hemoglobinuria.	Hillmen, P.; Young, N.S.; Schubert, J.; Brodsky, R.A.; Socie, G., et al
	2005	Pharmacokinetics and 24-week efficacy/safety of dual boosted saquinavir/lopinavir/ritonavir in nucleoside-pretreated children.	Ananworanich, J.; Kosalaraksa, P.; Hill, A.; Siangphoe, U.; Bergshoeff, A.S., et al
	2004	Pharmacokinetic study of saquinavir hard gel caps/ritonavir in HIV-1-infected patients: 1600/100 mg once-daily compared with 2000/100 mg once-daily and 1000/100 mg twice-daily.	Autar, R.S.; Ananworanich, J.; Apateerapong, W.; Sankote, J.; Hill, A., et al